Dr. Yujie Wang, MD

Dr. Wang practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Wang's NPI, 1821415381, was assigned on March 23, 2014. Dr. Wang holds Washington license MD60773410.

Dr. Wang's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Wang's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Wang is also affiliated with Confluence Health Hospital | Central Campus. The medical group on file is UW Physicians. Dmand AI also links Dr. Wang to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Wang is licensed in Washington.

CMS data shows 209 Medicare services from Dr. Wang across 6 procedure codes in 2024, for 100 Medicare patients. Medicare paid $14,961 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 50 patients. 61% of them have high blood pressure, and 59% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 46, with 72% women.

In 2024, Dr. Wang wrote 346 Medicare Part D claims for 45 patients. 58% of them were for generic drugs. CMS names the drug for 218 of them, across 10 drugs with 11 or more claims each, at $355,789 in total drug cost. In 2023, CMS named 160 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Wang for performance year 2024, reported through an alternative payment model (APM). Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 64 papers to Dr. Wang, published from 2011 to 2025. 2023 was the busiest year, with 12. The most frequent topics are Particulate Matter, Stiff-Person Syndrome and Air Pollutants. Dr. Wang has published most often in Front Neurol. Dr. Wang's most frequent co-authors are Scott Douglas Newsome, DO, Ellen Mahar Mowry, MD and Debbie Sue Gipson, MD.

CMS Open Payments shows 7 general payments to Dr. Wang from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 94% of the total. TG Therapeutics, Inc. paid the most, $900.